LY96 and adrenal cortex carcinoma: KM analysis revealed that patient with high LY96 expression exhibited longer DSS than patients with low LY96 expression in ACC, CESC, SKCM, and THCA (Figures 4A,B,J,K), however, patients with high LY96 expression exhibited shorter DSS in COAD, GBM, KICH, KIRC, KIRP, LGG, and UVM (Figures 4C–I, L).